What is Apyx Medical Inc (APYX) stock price today?

Apyx Medical Inc (APYX) currently trades at $3.46 per share. The stock has a market capitalization of $144.73M and a P/E ratio of —x.

Is APYX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Apyx Medical Inc has a Smart Value Score of 40/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Apyx Medical Inc's revenue and earnings?

Apyx Medical Inc has trailing twelve-month (TTM) revenue of $52.84M with profit margins of -21.20%. Earnings per share (EPS) is $-0.27.

Is APYX stock overvalued or undervalued?

Based on our DCF model, Apyx Medical Inc's intrinsic value is $7.09, representing a margin of safety of 44.71%. The stock currently trades at a P/E of —x.

APYX

Apyx Medical Inc

NASDAQ: APYX · HEALTHCARE · MEDICAL DEVICES

$3.46

-5.72% today

Updated 2026-04-29

Market cap

$144.73M

P/E ratio

—

P/S ratio

2.74x

EPS (TTM)

$-0.27

Dividend yield

—

52W range

$1 – $5

Volume

0.1M

Market cap

$144.73M

P/E ratio

—

P/S ratio

2.74x

EPS (TTM)

$-0.27

Dividend yield

—

52W range

$1 – $5

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

6.7

Growth

5.0

Quality

C+

2.5

Profitability

7.7

Valuation

B+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$6.40

+84.97%

12-Month target

—

Intrinsic (DCF)

$7.09

Margin of safety

+44.71%

1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 34.70% QoQ

+ 44.71% below intrinsic value

Risks

- Thin margins at -21.20%

- Negative free cash flow $-2.81M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$44.51M	$52.35M	$48.10M	$52.84M	$52.84M
Net income	$-23.18M	$-18.71M	$-23.46M	$-11.21M	$-1.30M
EPS	—	—	—	—	$-0.27
Free cash flow	$-21.29M	$-5.78M	$-18.77M	$-9.12M	$-2.81M
Profit margin	-52.09%	-35.75%	-48.78%	-21.22%	-21.20%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
APYX	$144.73M	40	6.7	2.5	7.7	5.0	+44.71%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Apyx Medical Inc trades at $3.46. Our Smart Value Score of 40/100 indicates the stock is fair. TTM revenue stands at $52.84M. with profit margins at -21.20%. Our DCF model estimates intrinsic value at $7.09.

Frequently asked questions

What is Apyx Medical Inc's stock price?

Apyx Medical Inc (APYX) trades at $3.46.

Is Apyx Medical Inc overvalued?

Smart Value Score 40/100 (Grade D, Sell). DCF value $7.09.

What is the price target of Apyx Medical Inc (APYX)?

The analyst target price is $6.40, representing +85.0% upside from the current price of $3.46.

What is the intrinsic value of Apyx Medical Inc (APYX)?

Based on our DCF model, intrinsic value is $7.09, a +44.7% margin of safety versus $3.46.

What is Apyx Medical Inc's revenue?

TTM revenue is $52.84M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.74x

ROE-76.10%

Beta1.54

50D MA$3.68

200D MA$3.21

Shares out0.04B

Float0.03B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

APYX vs LLY →APYX vs JNJ →APYX vs ABBV →Stock screener →